{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:17:28Z","timestamp":1794266248865,"version":"4.9.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lysophosphatidic acid (LPA) is a naturally occurring phospholipid that regulates cell proliferation, survival, and migration. However, its role on human multiple myeloma (MM) cells is largely unknown. In this study, we show that LPA, which is highly elevated in MM patients, plays an important role in protecting human MM cells against proteasome inhibitor (PI)-induced apoptosis. LPA bound to its receptor LPAR2 activated its downstream MEK1\/2-ERK1\/2 signaling pathway and enhanced oxidative phosphorylation (OXPHOS) in mitochondria in MM cells. Increased OXPHOS activity produced more NAD<jats:sup>+<\/jats:sup> and ATP, reduced proteasome activity, and enhanced protein folding and refolding in endoplasmic reticulum (ER), leading to induction of MM resistance to PIs. Importantly, inhibiting LPAR2 activity or knocking out LPAR2 in MM cells significantly enhanced MM sensitivity to PI-induced apoptosis in vitro and in vivo. Interestingly, primary MM cells from LPA-high patients were more resistant to PI-induced apoptosis than MM cells from LPA-low patients. Thus, our study indicates that LPA-LPAR2-mediated signaling pathways play an important role in MM sensitivity to PIs and targeting LPA or LPAR2 may potentially be used to (re)sensitize patients to PI-based therapy.<\/jats:p>","DOI":"10.1186\/s13045-022-01269-5","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T11:21:02Z","timestamp":1651922462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors"],"prefix":"10.1186","volume":"15","author":[{"given":"Pan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Ravi","family":"Pingali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"issue":"2","key":"1269_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/cancers12020407","volume":"12","author":"V Pinto","year":"2020","unstructured":"Pinto V, Bergantim R, Caires HR, Seca H, Guimaraes JE, Vasconcelos MH. Multiple myeloma: available therapies and causes of drug resistance. Cancers (Basel). 2020;12(2):407.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"1269_CR2","doi-asserted-by":"publisher","first-page":"8456","DOI":"10.1158\/0008-5472.CAN-08-2213","volume":"68","author":"S Hong","year":"2008","unstructured":"Hong S, Qian J, Yang J, Li H, Kwak LW, Yi Q. Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth. Cancer Res. 2008;68(20):8456\u201364.","journal-title":"Cancer Res"},{"issue":"1","key":"1269_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood.2020009856","volume":"139","author":"Q Wang","year":"2022","unstructured":"Wang Q, Lin Z, Wang Z, Ye L, Xian M, Xiao L, Su P, Bi E, Huang YH, Qian J, et al. RARgamma activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 2022;139(1):59\u201372.","journal-title":"Blood"},{"issue":"2","key":"1269_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/cancers12020265","volume":"12","author":"S Ito","year":"2020","unstructured":"Ito S. Proteasome inhibitors for the treatment of multiple myeloma. Cancers (Basel). 2020;12(2):265.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1269_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clml.2018.08.016","volume":"19","author":"X Leleu","year":"2019","unstructured":"Leleu X, Martin TG, Einsele H, Lyons RM, Durie BGM, Iskander KS, Ailawadhi S. Role of proteasome inhibitors in relapsed and\/or refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2019;19(1):9\u201322.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"1269_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0217-3","volume":"51","author":"D Kim","year":"2019","unstructured":"Kim D, Li HY, Lee JH, Oh YS, Jun HS. Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1\/MAPK\/KLF5 signaling. Exp Mol Med. 2019;51(2):1\u201310.","journal-title":"Exp Mol Med"},{"key":"1269_CR7","doi-asserted-by":"publisher","first-page":"16406","DOI":"10.1038\/srep16406","volume":"5","author":"I Kostic","year":"2015","unstructured":"Kostic I, Fidalgo-Carvalho I, Aday S, Vazao H, Carvalheiro T, Graos M, Duarte A, Cardoso C, Goncalves L, Carvalho L, et al. Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions. Sci Rep. 2015;5:16406.","journal-title":"Sci Rep"},{"key":"1269_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/1471-2407-14-432","volume":"14","author":"IJ Brusevold","year":"2014","unstructured":"Brusevold IJ, Tveteraas IH, Aasrum M, Odegard J, Sandnes DL, Christoffersen T. Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells. BMC Cancer. 2014;14:432.","journal-title":"BMC Cancer"},{"issue":"1","key":"1269_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-020-00367-5","volume":"6","author":"LHM Geraldo","year":"2021","unstructured":"Geraldo LHM, Spohr T, Amaral RFD, Fonseca A, Garcia C, Mendes FA, Freitas C, dosSantos MF, Lima FRS. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct Target Ther. 2021;6(1):45.","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"1269_CR10","doi-asserted-by":"publisher","first-page":"11272","DOI":"10.1074\/jbc.M113.537175","volume":"289","author":"P Tsvetkov","year":"2014","unstructured":"Tsvetkov P, Myers N, Eliav R, Adamovich Y, Hagai T, Adler J, Navon A, Shaul Y. NADH binds and stabilizes the 26S proteasomes independent of ATP. J Biol Chem. 2014;289(16):11272\u201381.","journal-title":"J Biol Chem"},{"issue":"6366","key":"1269_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/356260a0","volume":"356","author":"I Braakman","year":"1992","unstructured":"Braakman I, Helenius J, Helenius A. Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum. Nature. 1992;356(6366):260\u20132.","journal-title":"Nature"},{"issue":"5","key":"1269_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2008.10.011","volume":"135","author":"PI Merksamer","year":"2008","unstructured":"Merksamer PI, Trusina A, Papa FR. Real-time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions. Cell. 2008;135(5):933\u201347.","journal-title":"Cell"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-022-01269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-022-01269-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-022-01269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T11:30:05Z","timestamp":1651923005000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-022-01269-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1186\/s13045-022-01269-5","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) and Institutional Review Board (IRB) of Houston Methodist Research Institute (Protocol No. 0918-0053; IRB #Pro00019970). All animals received humane care in compliance with the \u201cPrinciples of Laboratory Animal Care\u201d formulated by the National Society for Medical Research and the \u201cGuide for the Care and Use of Laboratory Animals\u201d prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 86-23, revised 1996).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}